Anti-tenascin C antibodies and uses thereof
Abstract:
There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.
Public/Granted literature
Information query
Patent Agency Ranking
0/0